<?xml version="1.0" encoding="UTF-8"?>
<doi_batch version="5.3.1" xmlns="http://www.crossref.org/schema/5.3.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xsi:schemaLocation="http://www.crossref.org/schema/5.3.1 http://www.crossref.org/schema/deposit/crossref5.3.1.xsd">
 <head>
  <doi_batch_id>aspg-26-2201-1792476788</doi_batch_id>
  <timestamp>20261020061308</timestamp>
  <depositor>
   <depositor_name>American Scientific Publishing Group</depositor_name>
   <email_address>admin@americaspg.com</email_address>
  </depositor>
  <registrant>American Scientific Publishing Group</registrant>
 </head>
 <body>
  <journal>
   <journal_metadata language="en">
    <full_title>Journal of Social Problems Research</full_title>
    <abbrev_title>JSPR</abbrev_title>
    <issn media_type="electronic">2995-3200</issn>
   </journal_metadata>
   <journal_issue>
    <publication_date media_type="online">
     <year>2023</year>
    </publication_date>
    <journal_volume>
     <volume>4</volume>
    </journal_volume>
    <issue>1</issue>
   </journal_issue>
   <journal_article publication_type="full_text">
    <titles>
     <title>Acceptance level of the papillomavirus vaccine</title>
    </titles>
    <contributors>
     <person_name sequence="first" contributor_role="author">
      <given_name>Melba E. Narváez</given_name>
      <surname>Jaramillo</surname>
      <affiliations>
       <institution>
        <institution_name>Universidad Regional Autónoma de los Andes (UNIANDES-Tulcán). Ecuador.</institution_name>
       </institution>
      </affiliations>
     </person_name>
     <person_name sequence="additional" contributor_role="author">
      <given_name>Mayra A. Guerrero</given_name>
      <surname>Ayala</surname>
      <affiliations>
       <institution>
        <institution_name>Universidad Regional Autónoma de los Andes (UNIANDES-Tulcán). Ecuador.</institution_name>
       </institution>
      </affiliations>
     </person_name>
     <person_name sequence="additional" contributor_role="author">
      <given_name>Dannya A. Flores</given_name>
      <surname>Jurado</surname>
      <affiliations>
       <institution>
        <institution_name>Universidad Regional Autónoma de los Andes (UNIANDES-Tulcán). Ecuador.</institution_name>
       </institution>
      </affiliations>
     </person_name>
     <person_name sequence="additional" contributor_role="author">
      <given_name>Olga Mireya A.</given_name>
      <surname>Pico</surname>
      <affiliations>
       <institution>
        <institution_name>Universidad Regional Autónoma de los Andes (UNIANDES-Tulcán). Ecuador.</institution_name>
       </institution>
      </affiliations>
     </person_name>
    </contributors>
    <jats:abstract>
     <jats:p>This article is made to have identified low acceptance of the HPV-HPV vaccine, illustrates the level of acceptance of the HPV vaccine in the parents of girls between 9 and 11 years of age and generate information that will help guide health promotion. It is a bibliographic, descriptive, field, cross-sectional study of quantitative modality by the indicators that show this research and qualitative by identifying important characteristics of the factors related to the non-acceptance of the HPV vaccine, the survey was used as a technique of study. 100% of the target population is included in the research at the site of application. Result of the investigation shows the reality perceived in the population about the vaccine, such as the fear of side effects, infertility, develop some related infection, deaths related to the vaccine, being clear the little information received by the population about the vaccine, parents did not have enough knowledge and information about the relationship with cervical cancer and the vaccine creating barriers that made it difficult to access their consent and acceptance. The results of the study make it possible to assert that information is the fundamental basis of prevention actions in health, allows to report that its sole purpose of administration is to immunize against infections caused by HPV and thus decrease the incidence of cervical cancer by HPV in the future.</jats:p>
    </jats:abstract>
    <publication_date media_type="online">
     <year>2023</year>
    </publication_date>
    <pages>
     <first_page>35</first_page>
     <last_page>41</last_page>
    </pages>
    <publisher_item>
     <item_number item_number_type="article-number">2201</item_number>
    </publisher_item>
    <ai:program name="AccessIndicators">
     <ai:license_ref applies_to="vor">https://creativecommons.org/licenses/by/4.0/</ai:license_ref>
    </ai:program>
    <doi_data>
     <doi>10.54216/JSPR.040104</doi>
     <resource>https://www.americaspg.com/journal/26/article/2201</resource>
     <collection property="text-mining">
      <item>
       <resource mime_type="application/pdf">https://www.americaspg.com/storage/01698595135.pdf</resource>
      </item>
     </collection>
    </doi_data>
   </journal_article>
  </journal>
 </body>
</doi_batch>
